Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (DSGN)

CUSIP: 25056L103

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
+3,292,284
Put/Call ratio
2.2%
SEC-reported price per share
$9.38
Number of holders
116
Value change
+$35,421,791
Number of buys
65
Open additional details 1 more signal available
Number of sells
36
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,701,255

Security key

25056L103

Report period

Q4 2025

Institutions

116

Top holders

10

Ownership snapshot

Top reported holders of DSGN - Design Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Light Irrevocable Trust #...
Disclosed value leader
SR ONE CAPITAL MANAGEMENT...
Comparable rows
15/15
Latest evidence
30 Sep 2025
13D/G 13F Lead comparable stake: 6.9% 13D/G row: Light Irrevocable Trust #1 dated April 22, 2019 Showing 1-6 of 15 holder rows.

Quick read

Light Irrevocable Trust #1 dated April 22, 2019 leads the comparable SEC ownership view at 6.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Light Irrevocable Trust #1 dated April 22, 2019's linked filing trail.
Comparable ownership Top 5
Light Irrevocable Trust #1 dated ... 6.9%
Star Irrevocable Trust #1 dated A... 6.9%
Logos Global Management LP 4.4%
SR ONE CAPITAL MANAGEMENT, LP 10%
Point72 Asset Management, L.P. 5.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Light Irrevocable Trust #1 dated April 22, 2019
13D/G
6.9%
$16,257,665
3,834,355 shares
$0 31 Dec 2024
Star Irrevocable Trust #1 dated April 22, 2019
13D/G
6.9%
$16,257,665
3,834,355 shares
$0 31 Dec 2024
Logos Global Management LP
13F 13D/G
Company · Arsani William
4.4%
from 13D/G
$27,522,150
3,655,000 shares
30 Sep 2025
SR ONE CAPITAL MANAGEMENT, LP
13F
Company
13F
10%
$49,144,364
6,526,476 shares
30 Sep 2025
Point72 Asset Management, L.P.
13F
Company
13F
5.3%
$25,154,353
3,340,552 shares
30 Sep 2025
BlackRock, Inc.
13F
Company
13F
3.3%
$15,394,241
2,044,388 shares
30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
116
Shares
38,119,020
Rows available
116
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 holders
94
Q4 2025 holders
116
Holder diff
22
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .